Plunkett Research Online: AngioGenex Inc

ANGIOGENEX INC (AGGX:PINX) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

AngioGenex, Inc. is a biopharmaceutical company, focuses on the development of products that are used in the treatment, diagnosis and prognosis of cancer. The company primarily engages in the research to develop anti-cancer strategies using the field of antiangiogenesis. The company’s development .....



AngioGenex Inc
Ticker: AGGX
Exchange: PINX
Parent Company:
Year Established:
Employees:
Fiscal Year Ends in

Phone: 212 874-6008
Fax: 212 874-5027
Address: 425 Madison Avenue
Suite 902
New York, NY 10017 United States

Types Of Business
Industry Ranks

Industry NAICS code:

Pharmaceuticals
ContactsDescription
Martin MurrayCFO/Director/Treasurer/Secretary
William GarlandCOO/Director/CEO
See More
AngioGenex, Inc. is a biopharmaceutical company, focuses on the development of products that are used in the treatment, diagnosis and prognosis of cancer. The company primarily engages in the research to develop anti-cancer strategies using the field of antiangiogenesis. The company’s development .....See More See More

Auditor: Willams & Webster, P.S.
Legal Advisor:
Table could not be created because no data was found
Brands, Divisions and AffiliatesTop Salaries
NameTitleSalary (US$)Bonus (US$)
Other ThoughtsCorporate Culture

Apparent Female Officers or Directors: